Change in Directors/KMP
Vital Chemtech Announces Director Changes
Vital Chemtech appointed two independent directors and recorded the resignations of two independent directors, effective November 3, 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
6
Bullish
3
Bearish
37
Neutral
6
Bullish
3
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Industrial Manufacturing
Industrial Products
120 Cr
Low Risk
38.9
44.5
13.5
1.2
69.40
35.40
Sales CAGR
Profit CAGR
ROE
ROCE

Vital Chemtech Ltd (VITAL) is currently trading at 49.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Vital Chemtech Limited is a manufacturer of phosphorus-based chemicals, with products like Phosphorus Trichloride and Phosphorus Pentachloride serving the lifesciences and crop care industries. The company operates a state-of-the-art manufacturing facility in the Dahej, Gujarat region, equipped with PLC and SCADA systems, ensuring high-quality production standards. Vital Chemtech Ltd has recently enhanced its production capacity significantly from 13,200 MT to 28,800 MT, highlighting its focus on scaling operations. In November 2022, the company went public, issuing 6.4 million equity shares, marking a substantial financial development. Vital Chemtech has expanded its corporate structure with subsidiaries, like Vital Synthesis Pvt Ltd and Vital Alkoxides Pvt Ltd, to broaden its operational scope.
Over the past 52 weeks, Vital Chemtech Ltd has traded between a low of ₹35.40 and a high of ₹69.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Vital Chemtech Ltd has a market capitalization of approximately 119.73. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Vital Chemtech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 38.87 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 119.73 Cr, Vital Chemtech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Vital Chemtech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Vital Chemtech Ltd is 38.87. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Vital Chemtech appointed Bhavik Shirish Pandit and Mukeshkumar Ganeshbhai Kanazariya as Additional Non-Executive Independent Directors. Their appointments take effect from November 3, 2026 and are proposed for five-year terms.
Change in Directors/KMP
Vital Chemtech appointed two independent directors and recorded the resignations of two independent directors, effective November 3, 2026.
Change in Directors/KMP
Vital Chemtech Limited reported the resignations of Independent Directors Ajay Kumar Agrawal and Deepakkumar Chaubisa, effective 3 November 2026, citing personal and professional reasons.